TY  - JOUR

T1  - Meta-analysis of effects of zoledronic acid (ZOL) on survival in metastatic bone disease (MBD): Survival in patients with high bone turnover.

JO  - J Clin Oncol

PY  - 2008/05/20

AU  - Cook RJ

AU  - Hirsh V

AU  - Major PP

AU  - Saad F

AU  - Dias R

AU  - Lipton A

AU  - Coleman RE

ED  - 

VL  - 26

IS  - 15_suppl

SP  - 20562

Y2  - 2025/10/10

ER  -